Treatment results of methotrexate and folinic acid as primary chemotherapy for nonmetastatic gestational trophoblastic neoplasia

Journal of the Medical Association of Thailand

Volumn 88, Issue 7, 2005, Pages 886-890

  Srisomboon, Jatupol ^a   Suprasert, Prapaporn ^a   Phongnarisorn, Chailert ^a   Charoenkwan, Kittipat ^a   Siriaree, Sitthicha ^a   Cheewakriangkrai, Chalong ^a   Tantipalakorn, Charuwan ^a   Kietpeerakool, Chumnan ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

Chemotherapy; Choriocarcinoma; Gestational trophoblastic neoplasia; Methotrexate

Indexed keywords

DACTINOMYCIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; METHOTREXATE;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; DRUG EFFICACY; DRUG RESISTANCE; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NONMETASTATIC TROPHOBLASTIC TUMOR; SIDE EFFECT; THAILAND; TROPHOBLASTIC TUMOR;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; GESTATIONAL TROPHOBLASTIC NEOPLASMS; HUMANS; LEUCOVORIN; METHOTREXATE; MIDDLE AGED; PREGNANCY; TREATMENT OUTCOME;

EID: 25144505710     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Srisomboon J, Ployleumsaeng D, Suprasert P, Phongnarisorn C, Pantusart A. A 14-year retrospective study of molar pregnancy in Maharaj Nakorn Chiang Mai Hospital: high incidence of persistent disease. Thai J Obstet Gynaecol 1999; 11: 17-22.
2. Curry SL, Hammond CB, Tyrey L, Creasman WT, Parker RT. Hydatidiform mole diagnosis, management, and long-term follow up of 341 patients. Obstet Gynecol 1975; 45: 1-8.
3. Morrow CP, Kletzsky OA, DiSaia PJ, Townsend DE, Mishell DR, Nakamura RM. Clinical and laboratory correlates of molar pregnancy and trophoblastic disease. Am J Obstet Gynecol 1977; 128: 424-30.
4. Lurain JR, Brewer JI, Torok EE, Halpern B. Natural history of hydatidiform mole after primary evacuation. Am J Obstet Gynecol 1983; 145: 591-5.
5. Kohorn EI. Hydatidiform mole and gestational trophoblastic disease in Southern Connecticut. Obstet Gynecol 1982; 59: 78-84.
6. Barter JF, Soong SJ, Hatch KD, Orr JW Jr, Partridge EC, Austin JM Jr, et al. Treatment of nonmetastatic gestational trophoblastic disease with oral methotrexate. Am J Obstet Gynecol 1987; 157: 1166-8.
7. Smith EB, Weed JC Jr, Tyrey L, Hammond CB. Treatment of nonmetastatic gestational trophoblastic disease: results of methotrexate alone versus methotrexate-folinic acid. Am J Obstet Gynecol 1982; 72: 413-8.
8. Homesley H, Blessing J, Rettenmaier M, Capizzi RL, Major F, Twiggs L. Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease. Obstet Gynecol 1990; 36: 56-9.
9. Berkowitz RS, Goldstein DP, Bernstein MR. Methotrexate infusion and folinic acid in primary therapy of nonmetastatic gestational trophoblastic tumors. Gynecol Oncol 1990; 36: 56-9.
10. Osathanondh R, Goldstein DP, Pastorfide GB. Actinomycin D as the primary agent for gestational trophoblastic disease. Cancer 1975; 36: 863-6.
11. Petrilli ES, Twiggs LB, Blessing JA, Teng NNH, Curry S. Single-dose actinomycin D treatment for nonmetastatic gestational trophoblastic disease. Cancer 1987; 60: 2173-6.
12. Lurain JR, Elfstrad EP. Single-agent methotrexate chemotherapy for the treatment of nonmetastatic gestational trophoblastic tumors. Am J Obstet Gynecol 1995; 172: 574-9.
13. Matsui H, Iitsuka Y, Seki K, Sekiya S. Comparison of chemotherapies with methotrexate, VP-16 and actinomycin-D in low-risk gestational trophoblastic disease: remission rates and drug toxicities. Gynecol Obstet Invest 1998; 46: 5-8.
14. th ed. St. Louis: Mosby; 2002: 621-4.
15. Lurain JR, Brewer JI, Torok EE, Halpern B. Gestational trophoblastic disease: treatment results at the Brewer Trophoblastic Disease Center. Obstet Gynecol 1982; 60: 354-60.
16. Hammond CB, Weed JC Jr, Currie JL. The role of operation in the current therapy of gestational trophoblastic disease. Am J Obstet Gynecol 1980; 136: 844-56.
17. Bagshawe KD, Dent J, Newlands ES, Begent RHJ, Rustin GJS. The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumours. Br J Obstet Gynaecol 1989; 96: 795-802.
18. Berkowitz RS, Goldstein DP, Bernstein MR. Ten years' experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease. Gynecol Oncol 1986; 23: 111-8.
19. Bagshawe KD, Wilde CE. Infusion therapy for pelvic trophoblastic fumors. Br J Obstet Gynaecol 1964; 71: 565-70.
20. Suzuka K, Matsui H, Iitsuka Y, Yamazawa K, Seki K, Sekiya S. Adjuvant hysterectomy in low-risk gestational trophoblastic disease. Obstet Gynecol 2001; 97: 431-4.
21. Mutch DG, Soper JT, Babevek CJ, Clarke-Pearson DL, Hammond CB. Recurrent gestational trophoblastic disease: experience of the Southeastern Regional Trophoblastic Disease Center. Cancer 1990; 66: 978-82.